Updated Jul 16, 2026
Wichterman Troy has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $909K.

Troy Wichterman is the Chief Financial Officer of BioLife Solutions Inc, a company specializing in bioproduction products for the cell and gene therapy industry. He has been involved in multiple SEC filings related to the company's financial activities.
| Role | Chief Financial Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 844 | $27.79 | $23K |
| 2026-06-22 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 937 | $26.04 | $24K |
| 2026-06-10 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 1.0K | $26.10 | $27K |
| 2026-04-10 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 844 | $19.27 | $16K |
| 2026-03-23 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 3.7K | $19.12 | $72K |
| 2026-03-05 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale [10b5-1] | 588 | $20.74 | $12K |
| 2026-02-26 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 25.5K | $22.65 | $578K |
| 2026-02-26 | BLFS | BIOLIFE SOLUTIONS INC | A — Grant or award | 64.9K | — | |
| 2026-02-26 | BLFS | BIOLIFE SOLUTIONS INC | A — Grant or award | 31.1K | — | |
| 2025-12-05 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 30.0K | $25.72 | $772K |
| 2025-10-09 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 833 | $27.36 | $23K |
| 2025-09-11 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 1.0K | $26.83 | $28K |
| 2025-08-26 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 590 | $25.44 | $15K |
| 2025-07-07 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 877 | $22.27 | $20K |
| 2024-11-29 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale [10b5-1] | 581 | $27.20 | $16K |
| 2024-11-14 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale [10b5-1] | 147 | $26.19 | $4K |
| 2024-11-01 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale [10b5-1] | 894 | $23.15 | $21K |
Troy Wichterman is the Chief Financial Officer of BioLife Solutions Inc, a company specializing in bioproduction products for the cell and gene therapy industry. He has been involved in multiple SEC filings related to the company's financial activities.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 9 open-market sales ($909K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wichterman Troy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.